Composition for Preventing or Treating Rheumatoid Arthritis
AssigneesKael-Gemvax Co., Ltd., Sang Jae KIM
InventorSang Jae Kim
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a composition for treating and preventing an rheumatoid arthritis, wherein the composition containing a peptide comprising amino acid sequence of SEQ ID NO: 1, a peptide having 80% or more sequence identity with the amino acid sequence of the peptide or a peptide which is a fragment thereof. According to the present invention, provided is a composition for prevention or treatment of rheumatoid arthritis having a. superior effect of treating and preventing rheumatoid arthritis with minimized side effect.
Claims23
A composition for prevention or treatment of rheumatoid arthritis, comprising:
- (a) a peptide comprising an amino acid sequence of SEQ ID NO:
- 1, (b) a peptide having at least 80% sequence identity with SEQ ID NO:
- 1 or (c) a peptide fragment thereof as an active ingredient.
(canceled)
A method for prevention or treatment of rheumatoid arthritis comprising administering to a subject in need thereof:
- (a) a peptide comprising an amino acid sequence of SEQ ID NO:
- 1, (b) a peptide having at least 80% sequence identity with SEQ ID NO:
- 1, or (c) a peptide fragment thereof.
A method for manufacturing a composition for prevention or treatment of rheumatoid arthritis comprising:
- (1) synthesizing (a) a peptide comprising an amino acid sequence of SEQ ID NO:
- 1, (b) a peptide having at least 80% sequence identity with SEQ ID NO:
- 1, or (c) a peptide which is a fragment thereof, and (2) formulating the peptide of (1) with an additive.
19-22. (canceled)
A peptide for prevention or treatment of rheumatoid arthritis comprising:
- (a) a peptide comprising an amino acid sequence of SEQ ID NO:
- 1, (b) a peptide having at least 80% sequence identity with SEQ ID NO:
- 1, or (c) a peptide fragment thereof.
24-27. (canceled)
A kit for prevention or treatment of rheumatoid arthritis comprising:
- a peptide, wherein the peptide comprises:
- (a) an amino acid sequence of SEQ ID NO:
- 1, (b) the peptide has at least 80% amino acid sequence homology with SEQ ID NO:
- 1, or (c) the peptide is a fragment thereof;
- and instructions comprising at least one of administration dose, administration route, administration frequency, and indication of the peptide.
29-34. (canceled)
Dependencies are inferred from the claim text.